Austwick's addition to Verona Pharma's board, with his exten...
Austwick's addition to Verona Pharma's board, with his extensive biopharmaceutical experience, is viewed positively. His expertise is anticipated to be beneficial for the potential launch of ensifentrine.
Press Release: Michael Austwick Joins Verona Pharma as Non-Executive Director
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3310Followers
0Following
8097Visitors
Follow